The influence of chronic WIN 55, 212-2 treatment on vaginal hyperalgesia, VEGF, and NGF in a rat model of endometriosis

Stacy L. McAllister, Pritam Sinharoy
In: The Journal of Pain · 2018 · vol. 19(3) , pp. S78 · doi:10.1016/j.jpain.2017.12.182 · W2793455926
article OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Chronic treatment with WIN 55, 212-2 reduced vaginal hyperalgesia and decreased vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) levels in a rat model of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK